
|Videos|December 9, 2021
The Pharmacology and Pharmacokinetics of Cabotegravir and Rilpivirine
In this video, Dr. Sherman describes the pharmacology and pharmacokinetics of cabotegravir and rilpivirine as long acting injectable antiretroviral therapy agents.
Advertisement
Pharmacy Times spoke with Dr. Elizabeth Sherman, PharmD, about her session at the ASHP Midyear 2021 conference, titled "Long Acting Antiretroviral Therapy for the Treatment and Prevention of HIV Infection”.
In this video, Dr. Sherman describes the pharmacology and pharmacokinetics of cabotegravir and rilpivirine as long acting injectable antiretroviral therapy agents.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pennsylvania Confirms First Measles Deaths in 35 Years as US Case Count Tops 2900
2
New Lipid Drugs and What Pharmacists Need to Know
3
Beyond GLP-1: Amylin, Glucagon Enter Obesity Care
4
FDA Approves Ustekinumab Injection for Pediatric Ulcerative Colitis, Expanding IBD Options for Children
5

































































































